93 7485 (Granisetron Hydrochloride 1 mg)
Pill with imprint 93 7485 is White, Capsule-shape and has been identified as Granisetron Hydrochloride 1 mg. It is supplied by Teva Pharmaceuticals USA.
Granisetron is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative; nausea/vomiting, radiation induced and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Granisetron 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7485
Granisetron Hydrochloride
- Imprint
- 93 7485
- Strength
- 1 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- 5ht3 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-7485 (Discontinued)
- Inactive Ingredients
-
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
polyethylene glycol 400,
magnesium stearate,
microcrystalline cellulose,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
More about granisetron
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 18 Reviews
- Drug class: 5HT3 receptor antagonists
Patient resources
- Drug Information
- Granisetron injection
- Granisetron transdermal
- Granisetron Oral, Intravenous (Advanced Reading)
- Granisetron Transdermal (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.